RHENFOR
Glaxo Group Limited
Mark For: RHENFOR® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88334351 |
| Registration Number | 6066758 |
| Mark Literal Elements | RHENFOR |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-06-02 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Merilee J. Arevalo |
| Attorney Docket Number | 82771811 |
| Law Office Assigned | L40 |
| Employee Name | MARTIN, CHRISTINE C |
Timeline
| 2019-03-11 | Application Filed |
| 2019-10-08 | Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED |
| 2019-10-08 | Status: Live/Pending |
| 2019-10-08 | Transaction Date |
| 2020-03-17 | Published |
| 2020-06-02 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-06-02 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-06-02 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Glaxo Group Limited |
| Address | 980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS |
| Legal Entity Type | Private Company Limited By Shares (prc) |
| Legal Entity State | ENGLAND |
Documents
 Drawing | JPEG | 2019-03-11 |
 TEAS Plus New Application | MULTI | 2019-03-11 |
| Offc Action Outgoing | MULTI | 2019-04-23 |
| XSearch Search Summary | XML | 2019-04-23 |
| Response to Office Action | APPLICATION/XML | 2019-10-03 |
| Amendment and Mail Process Complete | MULTI | 2019-10-04 |
| Suspension Letter | XML | 2019-10-08 |
| TEAS Response to Suspension Inquiry | XML | 2020-01-31 |
| Amendment and Mail Process Complete | MULTI | 2020-02-11 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-02-11 |
| Notice of Publication | XML | 2020-02-26 |
| Notification Of Notice of Publication | XML | 2020-02-26 |
| OG Publication Confirmation | XML | 2020-03-17 |
| Registration Certificate | 2020-06-02 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-06-02 | |
| PUBLISHED FOR OPPOSITION | 2020-03-17 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-17 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-26 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-10 | 66213 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-10 | 66213 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-10 | |
| ASSIGNED TO LIE | 2020-02-05 | 66213 |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-01-31 | |
| SUSPENSION LETTER WRITTEN | 2019-10-08 | 85324 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-10-08 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2019-10-08 | 6332 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-03 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-03 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-03 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-04-23 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-04-23 | 85324 |
| NON-FINAL ACTION E-MAILED | 2019-04-23 | 6325 |
| ASSIGNED TO EXAMINER | 2019-04-23 | 85324 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-03-28 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-03-14 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RHENFOR 88334351 not registered Live/Pending |
Glaxo Group Limited 2019-03-11 |
 RHENFOR 77650539 4296729 Dead/Cancelled |
Glaxo Group Limited 2009-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 